Yz. Hu et al., Safety and immunogenicity of lyophilized, live attenuated hepatitis A vaccine in non-human primate model, CHIN MED J, 113(4), 2000, pp. 332-335
Objective To evaluate the safety and immunogenicity of lyophilized, live at
tenuated hepatitis A vaccine (H2 strain) in rhesus monkeys.
Methods Nine adult rhesus monkeys were used as experimental animals. The rh
esus monkeys without anti-HAV were divided randomly into the aqueous vaccin
ation group (4 rhesus monkeys), the lyophilized vaccination group (3 rhesus
monkeys), and the control group (2 rhesus monkeys). Monkeys were inoculate
d by intramuscular injection, with control monkeys being inoculated with Mi
nimum Essential Medium Eagle (MEM). Following vaccination, the monkeys were
observed for the development of diarrhoea and other adverse side-effects,
such as changes in appetite, frequency of defaecation and stool consistency
for seven days. At the weeks 2, 3, 4, 6, 8, 10 and 12 positnoculation, the
peripheral blood was collected from all animals and assayed for anti-HAV a
nd alanine aminotransferase ( ALT) and aspartate aminotransferase (AST), at
weeks 0, 4 and 8 postinocuation, needle-biopsy specimens were taken at wee
ks 0, 4, 8 and 12, all monkeys were sacrificed and tissue samples were take
n from liver, lung, heart, kidney and brain for pathological examination at
week 12.
Results Animals were immunized with a dose of 7.0 logTCID(50)/ml which is s
table after freeze-drying. During the 12-week observation, no animals showe
d abnormal elevations of liver enzymes (ALT and AST) and no change in appet
ite or activity. Two monkeys (one in the aqueous group and the other in lyo
philized group) showed possible lesions at week 8. The lyophilized vaccine,
in addition to eliciting an anti-HAV IgG response similar to aqueous vacci
ne (P > 0.05), also showed IgM anti-HAV response at week 2 which was not ob
served with aqueous vaccine.
Conclusions These results demonstrate that lyophilized, live hepatitis A va
ccine is safe and highly immunogenic in primates, supporting its further ev
aluation in human clinical studies.